Paragon is a life science company that creates and invests in bioscience companies. They focus on artificial intelligence, gene therapy, synthetic biology, and biopharmaceuticals. Their portfolio includes Castle Creek Biosciences, Emalex Biosciences, Evozyne, Harmony Biosciences, Qlarity Imaging, and Skyline Biosciences. They also incubate new companies in development. Paragon aims to solve complex challenges by advancing science and stands at the intersection of human need, life science, and company creation.